Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market
December 19 2022 - 6:00AM
Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”), today
announced that that on December 16, 2022 it received written notice
from The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that
Nasdaq believes that Forward is a "public shell" pursuant to
Listing Rule 5101, and that the continued listing of its securities
is no longer warranted. We will not appeal this determination.
Therefore, we expect the trading of our American Depositary Shares
on The Nasdaq Capital Market to be suspended at the opening of
business on December 28, 2022, and that Nasdaq will file a Form
25-NSE with the U.S. Securities and Exchange Commission (the
“SEC”), which will remove Forward’s securities from listing and
registration on The Nasdaq Stock Market. Additionally, we intend to
file with the SEC a Form 15 requesting the suspension of Forward’s
reporting obligations.
Forward Pharma A/S Investor Relations
Contact:
Forward Pharma A/SClaus Bo Svendsen, MD, PhDChief Executive
OfficerInvestor Relationsinvestors@forward-pharma.com
Forward Pharma A/S
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024